Telomere instability in papillary bladder urothelial carcinomas: Comparison with grading and risk of recurrence

Indian Journal of Urology

Volumn 30, Issue 3, 2014, Pages 245-251

  Mucciardi, Giuseppe ^a   Gali', Alessandro ^a   Barresi, Valeria ^a   Mucciardi, Massimo ^a   Aguennouz, M'Hammemd ^a   Inferrera, Antonino ^a   Magno, Carlo ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Bladder cancer; non muscle invasive bladder cancer; telomerase; telomere; telomere binding proteins; urothelial carcinomas

Indexed keywords

EID: 84905899071     PISSN: 09701591     EISSN: 19983824     Source Type: Journal    
DOI: 10.4103/0970-1591.134241     Document Type: Article

References (26)

1. Kipling D, Wynford-Thomas D, Jones CJ, Akbar A, Aspinall R, Bacchetti S, et al. Telomere-dependent senescence. Nat Biotechnol 1999; 17: 313-4.
2. Campisi J. Cellular senescence as a tumour-suppressor mechanism. Trends Cell Biol 2001; 11: S27-31.
3. Reddel RR. The role of senescence and immortalization in carcinogenesis. Carcinogenesis 2000; 21: 477-84.
4. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-5.
5. Epstein JI, Amim MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathological classification of urothelial (transitional cell) neoplasm of the urinary bladder. The Bladder Consensus Conference Commettee. Am J Surg Pathol 1998; 22: 1435-48.
6. Sobin L, Gospodarowicz M, Wittekind C. TNM Classification of Malignant Tumours. USA: Wiley-Blackwell; 2009. p. 262-5.
7. Messing EM. Urothelialtumours of the urinary tract. Bladder Cancer. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ, editors. Campbell's Urology, 8th ed. Philadelphia: Saunders; 2002. p. 2732-65.
8. Sharpless NE, DePinho RA. Telomeres, stem cells, senescence, and cancer. J Clin Invest 2004; 113: 160-8.
9. Meeker AK, Argani P. Telomere shortening occurs early during breast tumourigenesis: A cause of chromosome destabilization underlying malignant transformation? J Mammary Gland Biol Neoplasia 2004; 9: 285-96.
10. Reddel RR. Alternative lengthening of telomeres, telomerase, and cancer. Cancer Lett 2003; 194: 155-62.
11. Lin Y, Miyamoto H, Fujinami K, Uemura H, Hosaka M, Iwasaki Y, et al. Telomerase activity in human bladder cancer. Clin Cancer Res 1996; 2: 929-32.
12. De Kok JB, Schalken JA, Aalders TW, Ruers TJ, Willems HL, Swinkels DW. Quantitative measurement of telomerase reverse transcriptase (hTERT) mRNA in urothelial cell carcinomas. Int J Cancer 2000; 87: 217-20.
13. Rahat MA, Lahat N, Gazawi H, Resnick MB, Sova Y, Ben-Ari G, et al. Telomerase activity in patients with transitional cell carcinoma: A preliminary study. Cancer 1999; 85: 919-24.
14. Okumura A, Mizuno I, Nagakawa O, Fuse H. Telomerase activity is correlated with lower grade and lower stage bladder carcinomas. Int J Urol 2004; 11: 1082-6.
15. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995; 14: 4240-8.
16. Siracusano S, Niccolini B, Knez R, Tiberio A, Benedetti E, Bonin S, et al. The simultaneous use of telomerase, cytokeratin 20 and CD4 for bladder cancer detection in urine. Eur Urol 2005; 47: 327-33.
17. Sanchini MA, Gunelli R, Nanni O, Bravaccini S, Fabbri C, Sermasi A, et al. Relevance of urine telomerase in the diagnosis of bladder cancer. JAMA 2005; 294: 2052-6.
18. Khalbuss W, Goodison S. Immunohistochemical detection of hTERT in urothelial lesions: A potential adjunct to urine cytology. Cytojournal 2006; 3: 18
19. Dettlaff-Pokora A, Matuszewski M, Schlichtholz B. Telomerase activity in urine sediments as a tool for noninvasive detection of bladder cancer. Cancer Lett 2005; 222: 83-8.
20. Eissa S, Swellam M, Ali-Labib R, Mansour A, El-Malt O, Tash FM. Detection of telomerase in urine by 3 methods: Evaluation of diagnostic accuracy for bladder cancer. J Urol 2007; 178: 1068-72.
21. Kamata S, Kageyama Y, Yonese J, Oshima H. Significant telomere reduction in human superficial transitional cell carcinoma. Br J Urol 1996; 78: 704-8.
22. Fernandez-Gomez J, Escaf Barmadah S, Gosalbez D, Rodriguez-Faba O, Jalon A, Gonzalez R, et al. Telomere length on bladder washing samples from patients with bladder cancer correlates with tumour characteristics flow cytometry method for quantitative fluorescence in situ hybridization (flow-FISH technique). Eur Urol 2005; 48: 432-7.
23. McGrath M, Wong JY, Michaud D, Hunter DJ, De Vivo I. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev 2007; 16: 815-9.
24. Okuda K, Bardeguez A, Gardner JP, Rodriguez P, Ganesh V, Kimura M, et al. Telomere length in the newborn. Pediatr Res 2002; 52: 377-81.
25. Epel ES, Blackburn EH, Lin J, Dhabhar FS, Adler NE, Morrow JD, et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA 2004; 101: 17312-5.
26. Leuenroth S, Riethdorf S, Erbersdobler A, Riethdorf L, Löning T, Huland H, et al. Detection of human telomerase RNA in the tumour-surrounding mucosa of bladder carcinomas as a marker for premalignant transformation. BJU Int 2005; 96: 553-7.